These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY. Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [Abstract] [Full Text] [Related]
6. [Long-term survival after 1 or more recurrences of Hodgkin's lymphomas]. Stamenkovic I, Alberto P, Mermillod B. Schweiz Med Wochenschr; 1982 Dec 04; 112(49):1805-7. PubMed ID: 7178880 [Abstract] [Full Text] [Related]
7. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Hoffmann C, Chow KU, Wolf E, Faetkenheuer G, Stellbrink HJ, van Lunzen J, Jaeger H, Stoehr A, Plettenberg A, Wasmuth JC, Rockstroh J, Mosthaf F, Horst HA, Brodt HR. Br J Haematol; 2004 May 04; 125(4):455-62. PubMed ID: 15142115 [Abstract] [Full Text] [Related]
8. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients. Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I. Bone Marrow Transplant; 2007 Oct 04; 40(7):651-8. PubMed ID: 17660837 [Abstract] [Full Text] [Related]
13. Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients. Sperotto A, Damiani D, Zaja F, Patriarca F, Geromin A, Cerno M, Stocchi R, Tiribelli M, Skert C, Rinaldi C, Fanin R. Adv Clin Path; 2002 Apr 04; 6(2):77-85. PubMed ID: 19753729 [Abstract] [Full Text] [Related]
14. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003]. Jacomet C, Lesens O, Villemagne B, Darcha C, Tournilhac O, Henquell C, Cormerais L, Gourdon F, Peigue-Lafeuille H, Travade P, Beytout J, Laurichesse H. Med Mal Infect; 2006 Mar 04; 36(3):157-62. PubMed ID: 16503104 [Abstract] [Full Text] [Related]
15. Prognostic impact of bone involvement in Hodgkin lymphoma. Feltl D, Markova J, Mocikova H, Dedeckova K, Kozak T. Neoplasma; 2008 Mar 04; 55(2):96-100. PubMed ID: 18237246 [Abstract] [Full Text] [Related]
16. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. Boué F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F, Billaud E, Raphael M, Lancar R, Costagliola D. J Clin Oncol; 2006 Sep 01; 24(25):4123-8. PubMed ID: 16896005 [Abstract] [Full Text] [Related]
17. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma. Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group. Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):19-30. PubMed ID: 17097834 [Abstract] [Full Text] [Related]